Malonamide derivatives as inhibitors of gamma-secretase for the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2005313582 (hide)

Owner F. Hoffman-La Roche AG

Inventors Flohr, Alexander; Jakob-Roetne Roland; Wostl, Wolfgang

Agent Spruson & Ferguson

Pub. Number AU-B-2005313582

PCT Pub. Number WO2006/061136

Priority 04106395.9 08.12.04 EP; 05100816.7 07.02.05 EP

Filing date 1 December 2005

Wipo publication date 15 June 2006

Acceptance publication date 2 June 2011

International Classifications

C07D 267/14 (2006.01) Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

28 June 2007 PCT application entered the National Phase

  PCT publication WO2006/061136 Priority application(s): WO2006/061136

2 June 2011 Application Accepted

  Published as AU-B-2005313582

16 June 2011 Corrigenda

  Applications Accepted - Name Index Under the name F. Hoffman-La Roche AG, Application No. 2005313582, under INID (71) correct the applicant name to F. Hoffmann-La Roche AG

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005313585-Hydrophobing polymer powder that can be redispersed in water

2005313581-Phenyl-piperazin methanone derivatives